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Abstract 
Over four million individuals in the United States 
currently suffer from Alzheimer's disease (AD), a 
devastating disorder of progressive dementia. 
Within the next several decades, AD is expected to 
affect over 22 million people globally. AD can only 
be definitively diagnosed by postmortem exami-
nation. Thus, investigation into the specific patho-
genesis of neuronal degeneration and death in AD 
on a biochemical level is essential for both earlier 
diagnosis and potential treatment and prevention 
options. Overproduction of amyloid [3-peptide (A[3) 
in the brain leads to both free radical oxidative 
stress and toxicity to neurons in AD. My under-
graduate biochemical studies with regard to AD 
explore the various ways in which free radical oxi-
dative stress might contribute to the pathology of 
AD. In particular, this review highlights studies 
using Af3-precursor mutations in animal models, 
and analysis of histone-DNA interactions. 
Introduction 
Acknowledged as a disease of progressive demen-
tia as early as 1910 by German psychologist Alois 
Alzheimer, questions concerning the specifics of 
Alzheimer's disease (AD) still plague the scientific 
community. With the modern burgeoning of tech-
nological approaches in molecular biology and bio-
chemistry, recent research has opened the door to 
understanding the basic mechanisms of the disor-
der (Markesbery, 1997). Over four million indi-
viduals in the United States currently suffer from 
AD, the fourth leading cause of death in the United 
States. Within the next several decades, AD is ex-
pected to affect over 22 million people globally 
(Butterfield et al., 2001}. 
Characterized by the progressive loss of 
memory and cognition, major pathological 
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hallmarks of the disease include neurofibrillary tangles 
(NFTs) , senile (neuritic) plaques (SPs), and synapse 
loss (Katzman and Saitoh, 1991) . Amyloid 13-peptide 
(AI3), in the form of insoluble fibril deposits, is the 
primary component of senile plaques. Currently, AD 
can only be definitively diagnosed by postmortem 
examination (Varadarajan et al., 2000) . Thus , 
investigation into the specific pathogenesis of neuronal 
degeneration and death in AD on a biochemical level 
is essential for earlier diagnosis and potential treatment 
and prevention options. Known risk factors for AD 
include: age, family history of dementia or AD, low 
educational level, low linguistic ability during early 
stages, and the presence of apolipoprotien E (APO-E) 
alleles. Of the APO-E2, APO-E3 , and APO-E4 alleles 
present in humans, the APO-E4 allele signifies a 
greater incidence of AD (Markesbery, 1997) . 
My undergraduate biochemical research with re-
gard to AD explores the various ways in which free 
radical oxidative stress might contribute to the pa-
thology of AD. Oxidative stress occurs when there 
are more reactive species (radicals) than antioxidant 
defenses and repair capacities in a system, such as 
the brain. In particular, this review will highlight stud-
ies using Al3-precursor mutations in animal models 
and analysis of histone-DNA interactions in AD. 
Role of A(3 in Oxidative Stress 
Our laboratory has proposed that overproduction of 
Al3leads to both free radical oxidative stress and tox-
icity to neurons in AD (Butterfield et al ., 2001 ; 2002; 
Butterfield and Lauderback, 2002; Varadarajan et al., 
2000). By inserting itself into neuronal membranes, 
soluble, aggregated Al3 may induce the formation of 
reactive oxygen species and reactive nitrogen species 
that lead to lipid peroxidation, protein oxidation, and 
protein modification by 4-hydroxy-2-trans-nonenal 
(HNE) and acrolein, the reactive products of lipid 
peroxidation. Furthermore, Al3-associated free-radi-
cal oxidative stress can affect free fatty-acid release 
(leading to tau polymerization), disruption of Ca2 + 
homeostasis, peroxynitrite formation, inflammatory 
response, impairment of mitochondria, and apoptosis. 
Al3-associated oxidation may also play a role in the 
modification and inhibition of several neuronal and 
glial transmembrane transport systems. This includes 
ion-motive ATPases, glutamate transporters, glucose 
transporters, GTP-coupled transmembrane signaling 
proteins, and polyamine transporters; functional loss 
in these systems proves destructive to the neurons, 
causing cell potential loss, excitotoxic glutamate ac-
cumulation, decreased glucose availability, decreased 
intracellular communication, and increased neurotox-
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icity (Butterfield et al., 2001 ; 2002; Butterfield and 
Lauderback, 2002) . 
The amyloid 13-peptide is derived from the normal 
processing of the amyloid precursor protein (APP). As 
Al3 is a normal soluble component found in plasma 
and cerebrospinal fluid, it is suspected that conver-
sion of soluble Al3 into insoluble fibrils may signify a 
critical step in disease onset, a sign of overproduction 
of Al3 (Varadarajan et al. , 2000). Presenilin-1 (PS1) 
appears to cause cleavage of APP, leading to increased 
Al3 production (Selkoe, 2001). Fibrillar Al3 binding to 
receptors increases advanced glycation end-products 
to induce oxidative stress and activate microglia (Yan 
et al., 1996) . 
Neurodegenerative sites in the AD brain corre-
spond to the presence of oxidative stress and increased 
Al3 deposits (Hensley et al., 1995) . Given the broad 
scope of cellular modifications observed in AD and 
the increased Al3 deposits in AD pathology, a free radi-
cal oxidation cascade, in which structural and func-
tional alterations would be seen with any protein or 
lipid structure attacked by a free radical, is feasible as 
a model for neuronal death in AD (Varadarajan et al., 
2000). 
Genetic Mutations: Studies of Amyloid 
Precursor Protein and Presenilin Genes 
Studies in familial AD indicate the central role of Al3 in 
AD pathogenesis and the presence of Al3-precursor 
mutations; specifically, mutations in the amyloid pre-
cursor protein (APP) and presenilin genes lead to over-
production of Al3 and to AD. As in Down's trisomy, 
APP is expressed on Chromosome 21; consequently, 
Down's syndrome patients exhibit increased Al3 de-
posits and eventually develop AD (Varadarajan et al., 
2000) . PS1 cleavage of APP could stimulate faulty 
processing of Al3 and increased Al3 production (Selkoe, 
2001). While the number of sporadic cases of AD over-
shadows the occurrence of familial AD cases, a com-
mon pathogenesis leading to senile plaque and 
neurofibrillary tangle formation is postulated for all 
forms of AD, corresponding to the similar neuropatho-
logic lesions seen in both familial and sporadic cases. 
Therefore, research in familial AD using transgenic 
mouse models is applicable to all forms of the disease 
(Kurt et al., 2001). 
Mice overexpressing mutant human APP genes in 
a single transgenic model show evidence of develop-
ing fibrillar cerebral Ab deposits similar to the Al3 de-
posits seen in AD. Cerebral Al3 deposits increase as 
well in single transgenic mouse models overexpressing 
mutant or wild-type human PS1 proteins. Yet, the single 
transgenic models do not show increased Al3 deposits 
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until later in adulthood. In APP /PS1 double mutant 
models, the mice develop increased fibrillar A[3 de-
posits in the hippocampus and cerebral cortex earlier 
than single transgenic mice (Kurt et al., 2001). 
Methods Related to Markers of 
Oxidative Stress 
Oxidative stress measures for protein oxidation and 
lipid peroxidation can be performed on synaptosomes 
prepared from brain samples obtained from the mu-
tant mice. Protein oxidation is measured through the 
ultra-violet (UV)-Vis, fluorescence, or immunochemi-
cal detection of protein carbonyl formation. Free radi-
cal attack on susceptible amino acid side chains can 
induce protein oxidation to form protein carbonyls, 
as can the interaction of proteins with the products of 
glycation and glycoxidation, or the products of lipid 
peroxidation such as acrolein and 4-hydroxy-2-
transnonenal (HNE). Protein carbonyls then react with 
2,4-dinitrophenylhydrazine to form a protein-bound 
hydrazone. This hydrazone is then detected using 
spectroscopic or immunochemical methods 
(Butterfield et al. , 2001). 
Due to the unsaturated bonds in the fatty acid b-
chain and the high solubility of nonpolar, paramag-
netic oxygen in lipid bilayers, like those found in 
membranes, oxidative stress is especially dangerous 
for lipids. Initiated by a free radical attack on a lipid, 
peroxyl radicals are formed when the lipid radical re-
acts with oxygen. These peroxyl radicals can react 
with other lipids to sustain the chain reaction. Many 
of the products of lipid peroxidation, such as the un-
saturated aldehydes acrolein and HNE, are toxic and 
act to induce oxidative modification of nearby pro-
teins. This chain reaction leads to dysfunctional pro-
teins and neuronal death (Butterfield et al., 2002) . 
A crude assessment of lipid peroxidation is the 
measurement of thiobarbituric acid reactive substances 
(TBARS) . Because thiobarbituric acid is highly reac-
tive with non-lipid moieties as well as lipid 
peroxidation products, TBARS provide a non-specific 
marker of lipid peroxidation in AD brains. TBARS fol-
low a thiobarbituric acid reaction and can be used to 
measure molondialdehyde, a secondary product of 
lipid peroxidation, through fluorescence studies 
(Butterfield et al ., 2001) . Because HNE is a reactive 
product of lipid peroxidation, HNE adduct formation 
measures also provide a marker of lipid peroxidation. 
HNE adduct formation is quantified using an 
immunoblotting technique to signify protein modifi-
cation as a secondary product of lipid peroxidation 
(Butterfield et al ., 2002) . 
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Role of Antioxidants 
This research will lead to studies to determine if the 
administration of various antioxidants, such as N-
acetyl cysteine (NAC) has an effect in slowing the 
manifestation of degenerative symptoms in oxidative 
stress conditions. NAC upregulates glutathione syn-
thesis, providing the limiting amino acid cysteine. Glu-
tathione is present in millimolar levels, is the most 
abundant endogenous antioxidant in the brain, and 
may act as the first line of defense against oxidative 
stress. Our laboratory has previously shown that 
intraparitoneal (i.p.) injection of NAC in mice pro-
tects against in-vitro hydroxyl radical-, acrolein-, and 
peroxynitrite-induced damage (Pocernich et al. , 2000; 
2001; Koppal et al., 1999). Furthermore, our 
laboratory's studies indicate that i.p. injection of NAC 
protects against the Complex 2 inhibitor, 3-Nitropionic 
acid, an agent that leads to pathology reminiscent of 
Huntington's disease (La Fontaine et al., 2000). From 
the mice that have been fed/injected with NAC, fu-
ture studies will measure protein carbonyl formation, 
TBARS, and HNE to determine the relative effect of 
an antioxidant in slowing the neurodegeneration in 
mutant mice. 
Antioxidants such as Vitamin E (a-, b-, g-, d-toco-
pherols and tocotrienols) also exhibit potential for treat-
ment or prevention options. Vitamin E is the major 
chain-breaking antioxidant that protects against lipid 
peroxidation at the early stages of free radical attack. 
The a-tocopherol form has been shown to reduce neu-
rotoxicity of A[3 in neuronal cell culture (Yatin et al., 
2000). The antioxidant role of a-tocopherol is most 
supported in AD, and it may play a role in the inhibi-
tion of glutamate-induced cell death (Halliwell, 2001). 
DNA Oxidation and Histone Studies 
In compacting into chromatin, DNA winds around an 
octamer of core histones. These histones, H1, H2A, 
H2B, H3, and H4, are rich in lysines in the N-termi-
nus, allowing for close interaction with DNA and ad-
jacent nucleosomes. Lysine is a basic amino acid, 
which allows for a strong ionic interaction with DNA 
(Butterfield and Lauderback, 2002). Histone acetyla-
tion, the substitution of an acetyl group for a hydro-
gen atom, weakens these interactions, allowing for 
the chromatin to open up to transcriptional factors (Li 
etal. , 1993). 
An imbalance in pro-oxidant over anti-oxidant 
factors characterizes an oxidatively stressed system, 
such as a brain in AD. As noted above, free radicals 
can cause a cascade of oxidative stress that includes 
protein oxidation and lipid peroxidation, but DNA 
f 
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oxidation also plays a role in the cascade of oxidative 
stress in AD. The DNA oxidation marker 8-hydroxy-
2-deoxyguanosine has been shown to be increased in 
mitochondrial and nuclear DNA in AD brain (Mecocci 
et al., 1994). His tones, the DNA binding proteins, are 
also susceptible to oxidative stress, as has been shown 
occurring with hydrogen peroxide treatment (Ullrich 
et al., 1999). 
HNE, a reactive end product of lipid peroxidation, 
can bind to lysine residues by Michael addition to 
cause protein modification; Michael addition is an 
organic reaction in which a ketone or an aldehyde is 
converted to an enolate or an imine in the presence of 
a base (Esterbauer et al., 1991). HNE significantly 
alters the conformation of cortical synaptosomal mem-
brane proteins, causing dysfunctional proteins 
(Subramaniam et al. , 1997}. Studies have shown that 
HNE is increased in AD brains (Markesbery and Lovell, 
1998) and AD ventricular fluid (Lovell et al., 1997}. 
HNE binds to and likely explains the loss of function 
of the major glutamate transporter in an AD brain 
(Lauderback et al., 2001) . Because it is present in the 
AD system and because it causes dysfunctional pro-
teins through oxidative modification, HNE may play 
a role in DNA oxidation in AD. 
Our laboratory has hypothesized that HNE causes 
conformational changes to histones, thus altering their 
DNA binding capabilities. DNA damage in AD may 
result subsequent to the disruption of histone-DNA 
interactions. Furthermore, HNE binding to histones 
may block histone acetylation, thereby potentially al-
tering both histone-DNA interactions and transcrip-
tion factor penetration. These hypotheses are tested 
in various ways. Electron paramagnetic resonance 
(EPR) spin-labeling shows whether or not HNE binds 
to histones and changes their conformation. Disturb-
ing the ionic strength should lessen the ionic histone-
DNA interaction; thus, differing the physiological ionic 
conditions may show an effect of HNE on histone-
DNA interaction. Gel electrophoresis is also used to 
analyze the effect of HNE on histone acetylation. A 
manuscript describing the results of this study is nearly 
ready for submission for peer-review (Drake et al. , 
2003). 
Conclusions 
Current research indicates that Alzheimer's disease 
(AD) arises due to neurodegeneration promoted by 
oxidative stress in the brain and the overproduction 
of amyloid ~-peptide (A~) . This oxidative stress can 
take the form of protein oxidation, lipid peroxidation, 
or DNA oxidation, which confound normal brain pro-
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cesses by disrupting lipid structure, protein function, 
and DNA binding capabilities. Prevention hope lies 
in the use of antioxidants such as Vitamin E and pub-
lic acknowledgment of the risk factors such as low 
education and linguistic capacities. Antioxidants like 
N-acetyl cysteine (NAC) also pose a future option for 
treatment. 
Because of the increasing life span, the effects of 
aging and neurodegeneration are becoming more 
prominent in the population, with the potential to 
evolve into a public health crisis in the near future. 
Considerable research currently focuses on possible 
treatment pathways and preventive measures for 
neurodegenerative diseases like AD. 
For the Bibliography, see the on-line version of 
this article at www.uky.edu/kaleidoscope/fall2003. 
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